Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Tolazoline

Tolazoline

Tolazoline structure

Tolazoline 

structure
  • CAS No:

    59-98-3

  • Formula:

    C10H12N2

  • Chemical Name:

    Tolazoline

  • Synonyms:

    1H-Imidazole,4,5-dihydro-2-(phenylmethyl)-;2-Imidazoline,2-benzyl-;Imidazoline,2-benzyl-;4,5-Dihydro-2-(phenylmethyl)-1H-imidazole;Artonil;Benzazoline;Benzidazol;2-Benzyl-4,5-imidazoline;2-Benzyl-2-imidazoline;Divascol;Imidalin;Kasimid;Lambril;Olitensol;Peripherine;Phenylmethylimidazoline;Prefaxil;Priscol;Priscoline;Tolazoline;Vasimid;Vasodil;Benzylimidazoline;2-Benzylimidazoline;Benzolin (vasodilator);Benzolin;Dilatol ASI;Tolazolin;Imidaline;2-Benzyl-4,5-dihydro-1H-imidazole;NSC 35110

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

Tolazoline(NSC35110; Imidaline) is a non-selective competitive α-adrenergic receptor antagonist.IC50 value:Target: α-adrenoceptor antagonistTolazoline can be synthesized by the heterocyclation of the ethyl ester of iminophenzylacetic acid with ethylene diamine, which forms the desired product. The structure of tolazoline is strikingly similar to α-adrenergic agonists, which are antiedema sympathomimetics.


Solid


Tolazoline is a member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group. It has a role as an alpha-adrenergic antagonist, an antihypertensive agent and a vasodilator agent.|A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.

Tolazoline Basic Attributes

160.22

160.22

200-448-9

CHH9H12AQ3

35110

DTXSID3023683

C - Cardiovascular system|M - Musculo-skeletal system

2933290090

Characteristics

24.4

1.5

Solid

1.1±0.1 g/cm3

174 °C

147 °C @ Press: 9 Torr

158.3±22.1 °C

1.596

alcohol: freely soluble

2-8°C

Oral-Mouse LD50: 350 mg/kg; Abdominal cavity-mouse LD50: 160 mg/kg

Flammable; emit toxic nitrogen oxide gas when heated

10.3None

10.3

Safety Information

3

20/21/22-36/37/38

26-28-36/37/39-45

NJ1925000

Xn

The warehouse is ventilated, low temperature and dry; stored and transported separately from food materials

P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, P501

H302

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 128 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

highly toxic

Drug Information

For the treatment of pulmonary artery anomalies

Tolazoline is a pulmonary vasodilator indicated used to decrease pulmonary vascular resistance (PVR) in persistent pulmonary hypertension of the newborn (PPHN).

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)|Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)

Vasodilation by means of a direct effect on peripheral vascular smooth muscle and indirect effects produced, in part, by release of endogenous histamine; tolazoline has moderate alpha-adrenergic blocking activity and has histamine agonist activity. Tolazoline usually reduces pulmonary arterial pressure and vascular resistance.

Benzalolin

Tolazoline Use and Manufacturing

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:160.22
XLogP3:2.6
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:2
Exact Mass:160.100048391
Monoisotopic Mass:160.100048391
Topological Polar Surface Area:24.4
Heavy Atom Count:12
Complexity:169
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.